Information  X 
Enter a valid email address

Alpha Growth PLC (ALGW)

  Print      Mail a friend

Tuesday 30 April, 2019

Alpha Growth PLC

BlackOak Alpha Growth Fund Launch

RNS Number : 4702X
Alpha Growth PLC
30 April 2019
 

Alpha Growth plc

("Alpha", or the "Company")

 

BlackOak Alpha Growth Fund Launch

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce that in partnership with SL Investment Management Limited ("SLIM"), a UK based full scope FCA regulated alternative investment fund manager, have launched the BlackOak Alpha Growth Fund ("BOAGF", or the "Fund").

 

Alpha Longevity Management Limited ("ALM", a wholly owned subsidiary of Alpha and a BVI FSC approved investment manager) in partnership with SLIM are the exclusive Managers to BOAGF. Both SLIM and Alpha are the General Partners of the Limited Partnership.

 

The Fund is an open-ended Cayman Island Exempt Limited Partnership investing in Life Settlements and is available to qualified global investors.  Requiring a minimum investment of $250,000, the Fund has a target return between 10% and 14%, and provides investors with liquidity through quarterly redemption windows. The Fund has a management fee of 1.5% per annum and a [annual] performance fee calculated as 20% of all returns in excess of the hurdle rate of 7%. Both the management and performance fees will be received by the General Partners. The fund is supported by third party advisors including Sadis Goldberg (USA law firm), KPMG (Cayman, USA, and Ireland), Applebys (Cayman law firm), LK Shields (Ireland law firm), Advance Fund Administration (Cayman), WB Financial (Cayman), and CAFICO Ireland.

 

The Fund has received commitments for initial investment seed capital of approximately $15m. Over the course of the next few weeks and beyond, Alpha and SLIM will be on-boarding the initial investment commitments and rolling out a comprehensive marketing strategy targeting family offices, ultra-high net worth individuals, private wealth managers, and fund of fund investors.  Updates on the Fund will be posted from time to time on its website.

 

Alpha and SLIM would like to thank all its advisors in their efforts to launch the BlackOak Alpha Growth Fund.

 

Danny Swick, Chief Executive Officer of Alpha, commented:

"Working through the holidays and three different regulatory jurisdictions, that caused a slight delay, we are really pleased to finally get BOAGF launched and into the hands of interested parties awaiting the opportunity. The hard work to create a global fund exemplifies the working relationship we have with our advisors and especially SLIM and our mutual understanding of the asset class and goals of providing a world class fund in which investor and manager interest are aligned to produce the target returns."

 

Rob Ireland, Managing Director of SLIM,:

"We are very excited about the launch of the Fund and to be working with Alpha on this project. As a long-established participant in the longevity asset industry, the creation of  BOAGF is a strategically important addition to our existing Life Settlement business.  Alpha and SL's skill sets compliment each other exceedingly well, and the creation of BOAGF in partnership with Alpha offers a formidable proposition for investors considering an investment in Life Settlement."

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

[email protected]



Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

[email protected]

 

About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

About SL Investment Management

Established in 1990, starting as the specialist in UK traded endowment policies, SLIM entered the US Life Settlement market in 2003, subsequently providing management or investment advice to global institutional investors across multiple portfolios that have acquired more than 2,800 policies with a face value in excess of $2.9 billion. SLIM has developed expertise in insurance‐based investment funds based on UK and US domiciled life policies.

SL is authorised and regulated by the Financial Conduct Authority as an Alternative Investment Fund Manager. SL is a founding member of the European Life Settlement Association and is dedicated to supporting the Life Settlement Industry to adopt recognisable standards to promote Transparency, a Code of Practice and Self Regulation. SL is also a member of the UK Association of Policy Market Makers founded in 1990.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PRLEAXLNADFNEFF

a d v e r t i s e m e n t